These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21546630)

  • 61. Acute renal failure following intravenous fusidic acid.
    Phillips AO; Streather C; Scoble J
    Nephrol Dial Transplant; 1993; 8(6):572. PubMed ID: 8394548
    [No Abstract]   [Full Text] [Related]  

  • 62. Chemotherapy of bronchitis.
    Jensen K
    Br Med J; 1970 Apr; 2(5701):112. PubMed ID: 4911777
    [No Abstract]   [Full Text] [Related]  

  • 63. The pharmacokinetics of fusidic acid.
    Reeves DS
    J Antimicrob Chemother; 1987 Oct; 20(4):467-76. PubMed ID: 3316149
    [No Abstract]   [Full Text] [Related]  

  • 64. CLINICAL EXPERIENCE WITH FUSIDIC ACID.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1245-6. PubMed ID: 14084710
    [No Abstract]   [Full Text] [Related]  

  • 65. The stereochemistry of fusidic acid.
    Godtfredsen WO; von Daehne W; Vangedal S; Marquet A; Arigoni D; Melera A
    Tetrahedron; 1965 Dec; 21(12):3505-30. PubMed ID: 5879166
    [No Abstract]   [Full Text] [Related]  

  • 66. [Fusidic acid as monotherapy: was it necessary to study it for skin and soft tissue infections?].
    Groupe Bibliographique de la SPILF
    Med Mal Infect; 2011 Nov; 41(11):629-30. PubMed ID: 22229153
    [No Abstract]   [Full Text] [Related]  

  • 67. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
    Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
    Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.
    Bulitta JB; Okusanya OO; Forrest A; Bhavnani SM; Clark K; Still JG; Fernandes P; Ambrose PG
    Antimicrob Agents Chemother; 2013 Jan; 57(1):498-507. PubMed ID: 23147726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In Vitro Antimicrobial Activities of Fusidic Acid and Retapamulin against Mupirocin- and Methicillin-Resistant Staphylococcus aureus.
    Park SH; Kim JK; Park K
    Ann Dermatol; 2015 Oct; 27(5):551-6. PubMed ID: 26512169
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe?
    Hon KL; Wang SS; Lee KK; Lee VW; Leung TF; Ip M
    J Drugs Dermatol; 2012 Jul; 11(7):861-4. PubMed ID: 22777230
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fusidic acid in dermatology.
    Wilkinson JD
    Br J Dermatol; 1998 Dec; 139 Suppl 53():37-40. PubMed ID: 9990411
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A multifunctional injectable, self-healing, and adhesive hydrogel-based wound dressing stimulated diabetic wound healing with combined reactive oxygen species scavenging, hyperglycemia reducing, and bacteria-killing abilities.
    Chen R; Wang P; Xie J; Tang Z; Fu J; Ning Y; Zhong Q; Wang D; Lei M; Mai H; Li H; Shi Z; Wang J; Cheng H
    J Nanobiotechnology; 2024 Jul; 22(1):444. PubMed ID: 39068417
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymyxin B and fusidic acid, a novel potent synergistic combination against
    Chen S; Zhou P; Wu C; Wang J; Zhou Y; Zhang J; Wang B; Zhao H; Rao L; Li M; Yu F; Lin C
    Front Microbiol; 2023; 14():1220683. PubMed ID: 37886061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream.
    Barbieri E; Cavagnis S; Boracchini R; Scamarcia A; Testa A; Ciarniello MG; Martinelli B; Cantarutti L; Giaquinto C; Cantarutti A
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutations in
    Poulton NC; Azadian ZA; DeJesus MA; Rock JM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0090422. PubMed ID: 35920665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pancytopenia in a patient treated with fusidic acid and niraparib: a case report.
    Damerval M; Bazan F; Omrani S; Hugues M; Roux MF; Mayer J
    Eur J Hosp Pharm; 2023 Sep; 30(5):e24. PubMed ID: 35232830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Novel Promazine Derivative Shows High
    Ronco T; Jørgensen NS; Holmer I; Kromann S; Sheikhsamani E; Permin A; Svenningsen SW; Christensen JB; Olsen RH
    Front Microbiol; 2020; 11():560798. PubMed ID: 33101232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
    Siala W; Rodriguez-Villalobos H; Fernandes P; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712650
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
    Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
    Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.
    Gupta A; Harris JJ; Lin J; Bulgarelli JP; Birmingham BK; Grimm SW
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5986-94. PubMed ID: 27458210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.